CpG oligodeoxynucleotides allow for effective adoptive T-cell therapy in chronic retroviral infection.

Abstract:

:Adoptive T-cell therapy in cancer or chronic viral infections is often impeded by the development of functional impairment of the transferred cells. To overcome this therapeutic limitation we combined adoptive transfer of naive, virus-specific CD8+ T cells with immunostimulative CpG oligodeoxynucleotides (ODNs) in mice chronically infected with the Friend retrovirus. The CpG-ODN co-injection prevented the T cells from developing functional defects in IFNgamma and granzyme production and degranulation of cytotoxic molecules. Thus, the transferred T cells were able to reduce chronic viral loads when combined with CpG-ODNs. This strategy provides a new approach for developing successful adoptive T-cell therapy against chronic infections.

journal_name

Blood

journal_title

Blood

authors

Kraft AR,Krux F,Schimmer S,Ohlen C,Greenberg PD,Dittmer U

doi

10.1182/blood-2006-06-022178

subject

Has Abstract

pub_date

2007-04-01 00:00:00

pages

2982-4

issue

7

eissn

0006-4971

issn

1528-0020

pii

blood-2006-06-022178

journal_volume

109

pub_type

杂志文章

相关文献

BLOOD文献大全
  • A crucial role for the homeodomain transcription factor Hhex in lymphopoiesis.

    abstract::The hematopoietically expressed homeobox gene, Hhex, is a transcription factor that is important for development of definitive hematopoietic stem cells (HSCs) and B cells, and that causes T-cell leukemia when overexpressed. Here, we have used an Hhex inducible knockout mouse model to study the role of Hhex in adult he...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-06-579813

    authors: Jackson JT,Nasa C,Shi W,Huntington ND,Bogue CW,Alexander WS,McCormack MP

    更新日期:2015-01-29 00:00:00

  • Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice.

    abstract::We developed 2bF9 transgenic mice in a hemophilia B mouse model with the expression of human factor IX (FIX) under control of the platelet-specific integrin alphaIIb promoter, to determine whether ectopically expressing FIX in megakaryocytes can enable the storage of FIX in platelet alpha-granules and corrects the mur...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-11-255612

    authors: Zhang G,Shi Q,Fahs SA,Kuether EL,Walsh CE,Montgomery RR

    更新日期:2010-08-26 00:00:00

  • Cobalamin (vitamin B12) and B12 binding proteins in hypereosinophilic syndromes and secondary eosinophilia.

    abstract::Serum cobalamin (vitamin B12) and unsaturated B12 binding capacity (UBBC) have been measured in 24 cases of hypereosinophilia: 16 were cases of hypereosinophilic syndrome (HES) and 8 of secondary eosinophilia. The two groups were similar with respect to absolute eosinophil counts. Serum cobalamin and UBBC were found t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zittoun J,Farcet JP,Marquet J,Sultan C,Zittoun R

    更新日期:1984-04-01 00:00:00

  • Prognostic significance of thrombocytosis in idiopathic sideroblastic anemia.

    abstract::In order to determine the prognostic significance of thrombocytosis in idiopathic sideroblastic anemia, the clinical courses of 17 patients were reviewed. Six patients (36%) had thrombocytosis, and none developed acute leukemia. Nine patients (53%) had normal platelet counts, and one developed acute leukemia. Two pati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Streeter RR,Presant CA,Reinhard E

    更新日期:1977-09-01 00:00:00

  • Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinoside.

    abstract::We investigated treatment with gemtuzumab ozogamicin (GO) in 51 patients aged 65 years or older with newly diagnosed acute myeloid leukemia (AML), refectory anemia (RA) with excess of blasts in transformation, or RA with excess blasts. GO was given in doses of 9 mg/m(2) of body-surface area on days 1 and 8 or, therape...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood.v99.12.4343

    authors: Estey EH,Thall PF,Giles FJ,Wang XM,Cortes JE,Beran M,Pierce SA,Thomas DA,Kantarjian HM

    更新日期:2002-06-15 00:00:00

  • The development of imatinib as a therapeutic agent for chronic myeloid leukemia.

    abstract::Imatinib has revolutionized drug therapy of chronic myeloid leukemia (CML). Preclinical studies were promising but the results of clinical trials by far exceeded expectations. Responses in chronic phase are unprecedented, with rates of complete cytogenetic response (CCR) of more than 40% in patients after failure of i...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2004-08-3097

    authors: Deininger M,Buchdunger E,Druker BJ

    更新日期:2005-04-01 00:00:00

  • Prostaglandin E2 enhances long-term repopulation but does not permanently alter inherent stem cell competitiveness.

    abstract::Hematopoietic stem cell (HSC) transplantation is a lifesaving therapy for malignant and nonmalignant hematologic diseases and metabolic disorders. Although successful, hematopoietic transplantation can be hindered by inadequate stem cell number or poor engrafting efficiency. To overcome these deficits, we and others h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-07-515288

    authors: Hoggatt J,Mohammad KS,Singh P,Pelus LM

    更新日期:2013-10-24 00:00:00

  • Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation.

    abstract::Cellular oxygen partial pressure is sensed by a family of prolyl-4-hydroxylase domain (PHD) enzymes that modify hypoxia-inducible factor (HIF)alpha subunits. Upon hydroxylation under normoxic conditions, HIFalpha is bound by the von Hippel-Lindau tumor suppressor protein and targeted for proteasomal destruction. Since...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-3980

    authors: Martin F,Linden T,Katschinski DM,Oehme F,Flamme I,Mukhopadhyay CK,Eckhardt K,Tröger J,Barth S,Camenisch G,Wenger RH

    更新日期:2005-06-15 00:00:00

  • Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling.

    abstract::The IFN-inducible immunity-related p47 GTPase Irgm1 has been linked to Crohn disease as well as susceptibility to tuberculosis. Previously we demonstrated that HSC quiescence and function are aberrant in mice lacking Irgm1. To investigate the molecular basis for these defects, we conducted microarray expression profil...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-328682

    authors: King KY,Baldridge MT,Weksberg DC,Chambers SM,Lukov GL,Wu S,Boles NC,Jung SY,Qin J,Liu D,Songyang Z,Eissa NT,Taylor GA,Goodell MA

    更新日期:2011-08-11 00:00:00

  • Hepatosplenic T-cell lymphoma: a rare but challenging entity.

    abstract::Hepatosplenic T-cell lymphoma (HSTCL) is a rare T-cell neoplasm that most commonly arises from a small subset of γ/δ T-cell receptor-expressing lymphocytes. HSTCL is more common in adolescent and young adults and has a rapidly progressive clinical course and poor outcome due to its refractoriness to conventional chemo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004118

    authors: Pro B,Allen P,Behdad A

    更新日期:2020-10-29 00:00:00

  • Rapid prenatal diagnosis of beta thalassemia using DNA amplification and nonradioactive probes.

    abstract::We used in vitro DNA amplification by the polymerase chain reaction and nonradioactive probes for prenatal diagnosis of beta thalassemia in Chinese from the Guangdong province. Exact molecular diagnoses were made in all 20 fetuses studied over a 6-month period. We conclude that this method of prenatal diagnosis for be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cai SP,Chang CA,Zhang JZ,Saiki RK,Erlich HA,Kan YW

    更新日期:1989-02-01 00:00:00

  • A lower molecular weight gamma-chain variant in a congenital abnormal fibrinogen (Kyoto).

    abstract::A gamma-chain variant with a lower molecular weight than the normal gamma chain was detected in a new congenital abnormal fibrinogen with impaired polymerization of the fibrin monomer and with normal release of fibrinopeptides A and B in a 45-year-old male. Purified fibrinogen analyzed on SDS-polyacrylamide gel electr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yoshida N,Okuma M,Moroi M,Matsuda M

    更新日期:1986-09-01 00:00:00

  • Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor.

    abstract::To determine whether the sensitivity of the human long-term culture-initiating cell (LTC-IC) assay could be increased, we have evaluated a spectrum of different fibroblast cell lines for their abilities to influence the number of cells detectable as LTC-IC, to influence LTC-IC maintenance, and/or to influence LTC-IC d...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hogge DE,Lansdorp PM,Reid D,Gerhard B,Eaves CJ

    更新日期:1996-11-15 00:00:00

  • Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.

    abstract::Anaplastic large cell lymphoma (ALCL) is an aggressive lymphoma that is frequently associated with the t(2;5)(p23;q35), resulting in expression of a fusion protein, nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), which can be detected by either monoclonal or polyclonal antibodies to the ALK protein. The clinical f...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gascoyne RD,Aoun P,Wu D,Chhanabhai M,Skinnider BF,Greiner TC,Morris SW,Connors JM,Vose JM,Viswanatha DS,Coldman A,Weisenburger DD

    更新日期:1999-06-01 00:00:00

  • Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling.

    abstract::Unfractionated heparin (UFH) is a widely used anticoagulant that has long been known to potentiate platelet responses to subthreshold doses of platelet agonists. UFH has been reported to bind and induce modest conformational changes in the major platelet integrin, αIIbβ3, and induce minor changes in platelet morpholog...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-307751

    authors: Gao C,Boylan B,Fang J,Wilcox DA,Newman DK,Newman PJ

    更新日期:2011-05-05 00:00:00

  • BB9 ACEs the HSC compartment.

    abstract::In an effort to discover specific markers to isolate human hematopoietic stem cells, Jokubaitis and colleagues report that the monoclonal antibody BB9 reacts with hematopoietic cells displaying morphologic, phenotypic, and/or functional properties of stem and progenitor cells throughout human ontogeny. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2007-12-126672

    authors: Yoder MC

    更新日期:2008-04-15 00:00:00

  • Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.

    abstract::We here investigate the occurrence of fluoride intake-associated alterations in patients with hematologic disease on triazol antifungal medication. Clinical, laboratory, and radiology data of overall 43 patients with hematologic malignancies taking voriconazole (n = 20), posaconazole (n = 8), and itraconazole (n = 4),...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-403030

    authors: Gerber B,Guggenberger R,Fasler D,Nair G,Manz MG,Stussi G,Schanz U

    更新日期:2012-09-20 00:00:00

  • Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells.

    abstract::We studied the cell kill induced by granulocyte-macrophage colony-stimulating factor (GM-CSF ) fused to Diphtheria Toxin (DT-GM-CSF ) in acute myeloid leukemia (AML) samples and in populations of normal primitive hemopoietic progenitor cells. AML samples from three patients were incubated in vitro with 100 ng/mL DT-GM...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Terpstra W,Rozemuller H,Breems DA,Rombouts EJ,Prins A,FitzGerald DJ,Kreitman RJ,Wielenga JJ,Ploemacher RE,Löwenberg B,Hagenbeek A,Martens AC

    更新日期:1997-11-01 00:00:00

  • DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells.

    abstract::The Y chromosome encodes male-specific minor histocompatibility (H-Y) antigens that stimulate T- and B-lymphocyte responses after sex-mismatched allogeneic hematopoietic cell transplantation (HCT). A CD8(+) cytotoxic T lymphocyte (CTL) clone that recognizes a novel HLA-B*2705-restricted H-Y antigen encoded by the DDX3...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-06-096313

    authors: Rosinski KV,Fujii N,Mito JK,Koo KK,Xuereb SM,Sala-Torra O,Gibbs JS,Radich JP,Akatsuka Y,Van den Eynde BJ,Riddell SR,Warren EH

    更新日期:2008-05-01 00:00:00

  • Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study.

    abstract::The role of glycosylated recombinant human granulocyte colony-stimulating factor (G-CSF) in the induction treatment of older adults with acute myeloid leukemia (AML) is still uncertain. In this trial, a total of 722 patients with newly diagnosed AML, median age 68 years, were randomized into 4 treatment arms: (A) no G...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood-2004-09-3728

    authors: Amadori S,Suciu S,Jehn U,Stasi R,Thomas X,Marie JP,Muus P,Lefrère F,Berneman Z,Fillet G,Denzlinger C,Willemze R,Leoni P,Leone G,Casini M,Ricciuti F,Vignetti M,Beeldens F,Mandelli F,De Witte T,EORTC\/GIMEMA Leukemi

    更新日期:2005-07-01 00:00:00

  • Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein.

    abstract::It has previously been shown that human granulocyte-macrophage colony-stimulating factor (GM-CSF) can be fused to a truncated diphtheria toxin (DT) to produce a recombinant fusion toxin that kills GM-CSF receptor-bearing cells. We now report that DT388-GM-CSF induces apoptosis and inhibition of colony formation in sem...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Frankel AE,Hall PD,Burbage C,Vesely J,Willingham M,Bhalla K,Kreitman RJ

    更新日期:1997-11-01 00:00:00

  • AC133, a novel marker for human hematopoietic stem and progenitor cells.

    abstract::AC133 is one of a new panel of murine hybridoma lines producing monoclonal IgG antibodies (mAbs) to a novel stem cell glycoprotein antigen with a molecular weight of 120 kD. AC133 antigen is selectively expressed on CD34(bright) hematopoietic stem and progenitor cells (progenitors) derived from human fetal liver and b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yin AH,Miraglia S,Zanjani ED,Almeida-Porada G,Ogawa M,Leary AG,Olweus J,Kearney J,Buck DW

    更新日期:1997-12-15 00:00:00

  • Blastic transformation of essential thrombocythemia: dual expression of myelomonoblastic/megakaryoblastic phenotypes.

    abstract::Three patients developed blastic transformation of essential thrombocythemia (tET). Morphological studies in all patients showed that the majority of blasts had either myeloblastic or myelomonoblastic differentiation. Immunologic assays of hematopoietic cells were performed in two patients. In patient 1, 86% of periph...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Frei-Lahr D,Barton JC,Hoffman R,Burkett LL,Prchal JT

    更新日期:1984-04-01 00:00:00

  • A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia.

    abstract::Essential thrombocythemia (ET) is characterized by abnormal megakaryopoiesis and enhanced thrombotic risk. Once-daily low-dose aspirin is the recommended antithrombotic regimen, but accelerated platelet generation may reduce the duration of platelet cyclooxygenase-1 (COX-1) inhibition. We performed a multicenter doubl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004596

    authors: Rocca B,Tosetto A,Betti S,Soldati D,Petrucci G,Rossi E,Timillero A,Cavalca V,Porro B,Iurlo A,Cattaneo D,Bucelli C,Dragani A,Di Ianni M,Ranalli P,Palandri F,Vianelli N,Beggiato E,Lanzarone G,Ruggeri M,Carli G,Ell

    更新日期:2020-07-09 00:00:00

  • Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group.

    abstract::We have conducted a pilot study to investigate the role of high-dose therapy and autologous bone marrow/stem cell transplantation (ASCT) during first complete or partial remission in 52 patients with poor-risk aggressive lymphoma. There were 42 patients with intermediate-grade or immunoblastic lymphoma who were consid...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Nademanee A,Molina A,O'Donnell MR,Dagis A,Snyder DS,Parker P,Stein A,Smith E,Planás I,Kashyap A,Spielberger R,Fung H,Wong KK,Somlo G,Margolin K,Chow W,Sniecinski I,Vora N,Blume KG,Niland J,Forman SJ

    更新日期:1997-11-15 00:00:00

  • Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

    abstract::Circulating endothelial progenitor cells (EPCs) are thought to contribute to angiogenesis following vascular injury, stimulating interest in their ability to mediate therapeutic angiogenesis. However, the number of EPCs in the blood is low, limiting endogenous repair, and a method to rapidly mobilize EPCs has not been...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-06-030577

    authors: Shepherd RM,Capoccia BJ,Devine SM,Dipersio J,Trinkaus KM,Ingram D,Link DC

    更新日期:2006-12-01 00:00:00

  • Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation.

    abstract::Scott syndrome, a bleeding disorder caused by defective phospholipid scrambling, has been associated with mutations in the TMEM16F gene. The role of TMEM16F in apoptosis- or agonist-induced phosphatidylserine (PS) exposure was studied in platelets from a Scott syndrome patient and control subjects. Whereas stimulation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-09-454314

    authors: van Kruchten R,Mattheij NJ,Saunders C,Feijge MA,Swieringa F,Wolfs JL,Collins PW,Heemskerk JW,Bevers EM

    更新日期:2013-03-07 00:00:00

  • Expression of the Fanconi anemia group A gene (Fanca) during mouse embryogenesis.

    abstract::About 80% of all cases of Fanconi anemia (FA) can be accounted for by complementation groups A and C. To understand the relationship between these groups, we analyzed the expression pattern of the mouse FA group-A gene (Fanca) during embryogenesis and compared it with the known pattern of the group-C gene (Fancc). Nor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Abu-Issa R,Eichele G,Youssoufian H

    更新日期:1999-07-15 00:00:00

  • Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study.

    abstract::Recombinant human interleukin-6 (IL-6) has previously been shown to increase platelet counts in normal and sublethally irradiated mice, dogs, and primates. To assess its tolerance and efficacy in clinical use, we performed a randomized phase Ib study in patients with ovarian carcinoma. IL-6 was administered during an ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: D'Hondt V,Humblet Y,Guillaume T,Baatout S,Chatelain C,Berlière M,Longueville J,Feyens AM,de Greve J,Van Oosterom A

    更新日期:1995-05-01 00:00:00

  • Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.

    abstract::CTLA-4 inhibits T-cell activation and protects against the development of autoimmunity. We and others previously showed that the coreceptor can induce T-cell motility and shorten dwell times with dendritic cells (DCs). However, it has been unclear whether this property of CTLA-4 affects both conventional T cells (Tcon...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-04-421420

    authors: Lu Y,Schneider H,Rudd CE

    更新日期:2012-11-29 00:00:00